Skip to content

Company information lookup

IMUGENE LIMITED (IMU)

An Australian immuno-oncology focused biopharmaceutical company developing HER2 +ve gastric and breast cancer vaccines. The Companys lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER-2/neu.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IMU 0.012 0% 0.011 0.012 0.000 0.000 0.000 0

IMUGENE LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IMU
Securities
Official Listing Date 24 November, 1993
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.imugene.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3142
Head Office Telephone 03 9824 5254
Head Office Fax 03 9822 7735
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Paul Hopper (Executive Chairman, Non Exec. Director)
Mr Charles Walker (CEO)
Dr Nicholas Ede (Executive Director)
Mr Otto Buttula (Non Exec. Director)
Dr Axel Hoos (Non Exec. Director)
Mr Phillip Hains (CFO)
Company Secretary Mr Justyn Stedwell
Mr Phillip Hains (Joint Co. Secretary)
Principal Activities An Australian immuno-oncology focused biopharmaceutical company developing HER2 +ve gastric and breast cancer vaccines. The Companys lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER-2/neu.

IMUGENE LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
08/10/2014 asterix Imugene HER-Vaxx patent granted in US 1 PDF
16/09/2014   Investor Presentation 26 PDF
15/09/2014 asterix Swiss Drug Manufacturer to Speed Her-Vaxx Development 1 PDF
08/09/2014 asterix Research Agreement with Medical University of Vienna 1 PDF
28/08/2014 asterix Appendix 4E and Annual Financial Report 71 PDF
28/08/2014   Investor Newsletter 4 PDF
26/08/2014 asterix Charles Walker appointed Imugene CEO 2 PDF
29/07/2014 asterix HER-Vaxx patent application receives US Notice of Allowance 1 PDF
25/07/2014 asterix Appendix 4C - quarterly 5 PDF
16/07/2014 asterix Mymetics Engaged to Manufacture HER-Vaxx 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
20 Oct 2014 0.012 0% 0.012 0.012 202,920
16 Oct 2014 0.012 -7.69% 0.012 0.012 50,000
15 Oct 2014 0.013 0% 0.013 0.013 150,000
13 Oct 2014 0.013 0% 0.013 0.013 1,621,000
10 Oct 2014 0.013 0% 0.013 0.013 84,342

* Volume of shares shown represents only those shares traded on ASX.

IMUGENE LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IMU. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IMU

Warrants & Structured Products

No warrants & Structured Products are available over the security IMU